AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (March 2, 2004). doi:10.1152/ajprenal.00401.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/F1136    most recent
00401.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffin, K. A.
Right arrow Articles by Bidani, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffin, K. A.
Right arrow Articles by Bidani, A. K.
Submitted on November 12, 2003
Accepted on February 23, 2004

Effect of calcium channel blockers on 'dynamic' and 'steady-state step' renal autoregulation

Karen A. Griffin1*, Rifat Hacioglu2, Isam Abu-Amarah1, Rodger Loutzenhiser3, Geoffrey A. Williamson2, and Anil K. Bidani1

1 Department of Internal Medicine, Loyola University Medical Center and Edward Hines VA Hospital, Maywood, IL, USA
2 Department of Electrical and Computer Engineering, Illinois Institute of Technology, Chicago, IL, USA
3 Department of Pharmacology & Therapeutics, University of Calgary, Calgary, Alberta, Canada

* To whom correspondence should be addressed. E-mail: kgriffi{at}lumc.edu.

Renal autoregulation (AR) mechanisms provide the primary protection against transmission of systemic pressures and hypertensive renal damage. However, the relative merits of the 'step' change vs. 'dynamic' methods for the assessment of AR capacity remain controversial. The effects of 48-72 hours of orally administered amlodipine ('L' type) and mibefradil ('T' type) calcium channel blockers (CCBs) on 'step' and 'dynamic' AR in Sprague- Dawley rats were compared. Both CCBs significantly impaired 'steady-state step' AR (autoregulatory indices = ~0.5 vs. ~0.1 in controls, p < 0.05; n=9-10/group). By contrast, dynamic AR compensation in separate conscious rats (n=12) was not significantly altered by either amlodipine (n=10) or mibefradil (n=6) (fractional gain in admittance ~0.4-0.5 in all groups at frequencies in the range of 0.0025 - 0.025 Hz). However, both CCBs tended to attenuate the myogenic resonance peak along with shifting it to a significantly slower frequency (p < 0.001) during 'dynamic' AR but no consistent effects were observed on the TGF resonance peak. While the reasons for the insensitivity of 'dynamic' vs. 'steady-state step' AR capacity estimates to CCBs remain to be established, the present data indicates that 'dynamic' AR methods may have a limited utility for assessing AR capacity, but may provide potentially important insights into the operational characteristics of AR control mechanisms. A strong correlation was also observed between the average conductance and the admittance gain at the heart beat frequency (r = 0.77, p < 0.001) suggesting that such parameters may provide additional and possibly more meaningful indices of BP transmission in conscious animals during 'dynamic' AR.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. D. Bell, G. F. DiBona, R. Biemiller, and M. W. Brands
Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1449 - F1456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Iliescu, R. Cazan, G. R. McLemore Jr., M. Venegas-Pont, and M. J. Ryan
Renal blood flow and dynamic autoregulation in conscious mice
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F734 - F740.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. A. Griffin, M. Abu-Naser, I. Abu-Amarah, M. Picken, G. A. Williamson, and A. K. Bidani
Dynamic blood pressure load and nephropathy in the ZSF1 (fa/facp) model of type 2 diabetes
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1605 - F1613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. A. Cupples and B. Braam
Assessment of renal autoregulation
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1105 - F1123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Just
Mechanisms of renal blood flow autoregulation: dynamics and contributions
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R1 - R17.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Loutzenhiser, K. Griffin, G. Williamson, and A. Bidani
Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1153 - R1167.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
N. Khosla and G. Bakris
Lessons Learned from Recent Hypertension Trials about Kidney Disease
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 229 - 235.
[Full Text] [PDF]


Home page
HypertensionHome page
S. Nathan, C. J. Pepine, and G. L. Bakris
Calcium Antagonists: Effects on Cardio-Renal Risk in Hypertensive Patients
Hypertension, October 1, 2005; 46(4): 637 - 642.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
I. Abu-Amarah, A. K. Bidani, R. Hacioglu, G. A. Williamson, and K. A. Griffin
Differential effects of salt on renal hemodynamics and potential pressure transmission in stroke-prone and stroke-resistant spontaneously hypertensive rats
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F305 - F313.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.